[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100308768":3},{"organization":4,"armGroups":7,"interventions":8,"overallOfficials":7,"centralContacts":13,"locations":19,"responsibleParty":34,"collaborators":7,"id":36,"slug":7,"hasResults":37,"nctId":38,"briefTitle":39,"officialTitle":40,"acronym":41,"eligibilityCriteria":42,"healthyVolunteers":37,"sex":43,"minAge":44,"maxAge":7,"enrollmentInfo":45,"targetDuration":7,"studyType":48,"phases":7,"briefSummary":49,"conditions":50,"keywords":7,"overallStatus":22,"whyStopped":7,"lastUpdateSubmitDate":53,"lastUpdatePostDateStruct":54,"startDateStruct":57,"completionDateStruct":59,"leadSponsor":61,"locationsCount":62},{"fullName":5,"class":6},"Universitaire Ziekenhuizen KU Leuven","OTHER",null,[9],{"type":10,"name":11,"description":12,"armGroupLabels":7,"otherNames":7},"DIAGNOSTIC_TEST","Breath analysis","Spectrometric analysis of exhaled breath as screening for opportunistic respiratory infections",[14],{"name":15,"role":16,"phone":17,"phoneExt":7,"email":18},"Toine Mercier, MD","CONTACT","+32 16 34 00 04","toine.mercier@uzleuven.be",[20],{"facility":21,"status":22,"city":23,"state":7,"zip":24,"country":25,"cosmosGeoPoint":26,"geoPoint":31,"contacts":32},"University Hospitals Leuven","RECRUITING","Leuven","3000","Belgium",{"type":27,"coordinates":28},"Point",[29,30],4.70093,50.87959,{"lat":30,"lon":29},[33],{"name":15,"role":16,"phone":17,"phoneExt":7,"email":18},{"type":35,"investigatorFullName":7,"investigatorTitle":7,"investigatorAffiliation":7,"oldNameTitle":7,"oldOrganization":7},"SPONSOR","100308768",false,"NCT03299608","Rapid Analysis of Infections by Spectrometry of Exhaled Breath","Exhaled Breath Analysis for Rapid Diagnosis in Opportunistic Respiratory Infections in Hematological Patients","RAISE","Inclusion Criteria:\n\n* Age ≥ 18y at start of study\n* One of the following diagnoses:\n\n  * De novo, refractory or relapsed AML\u002FMDS receiving intensive chemotherapy\n  * De novo, refractory or relapsed ALL\u002FT-lymphoblastic lymphoma receiving intensive chemotherapy\n  * Aplastic anemia requiring ATG therapy\n  * Any patient admitted for either autologous hematopoietic stem cell transplantation. Transplantation may not have been performed at time of enrolment.\n  * Any patient admitted with allogeneic hematopoietic stem cell transplantation within the last year, or planned during this admission.\n* Written informed consent obtained from the patient\n\nExclusion Criteria:\n\n* Hematological disease beyond the specified inclusion criteria\n* Signs of active respiratory infection\n* If previously enrolled: incomplete clearance of all signs of respiratory infection (both clinically, microbiologically and radiologically).","ALL","18 Years",{"count":46,"type":47},246,"ESTIMATED","OBSERVATIONAL","To quantify the diagnostic, prognostic and therapeutic value of spectrometric analysis of exhaled breath from hematological patients with respiratory infection.",[51,52],"Respiratory Tract Infections","Hematologic Diseases","2024-07-02",{"date":55,"type":56},"2024-07-03","ACTUAL",{"date":58,"type":56},"2019-06-21",{"date":60,"type":47},"2025-09",{"name":5,"class":6},1]